These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 2441416

  • 1. The effect of increased fetal hemoglobin production on the frequency of vaso-occlusive crisis in sickle cell disease.
    Dover GJ, Charache S.
    Prog Clin Biol Res; 1987; 240():277-85. PubMed ID: 2441416
    [No Abstract] [Full Text] [Related]

  • 2. Increasing fetal hemoglobin in sickle cell disease: comparisons of 5-azacytidine (subcutaneous or oral) with hydroxyurea.
    Dover GJ, Charache S, Boyer SH.
    Trans Assoc Am Physicians; 1984; 97():140-5. PubMed ID: 6085527
    [No Abstract] [Full Text] [Related]

  • 3. Objective indices of sickle cell painful crisis: decrease in RDW and percent dense cells and increase in ESR and fibrinogen.
    Lawrence C, Fabry ME.
    Prog Clin Biol Res; 1987; 240():329-36. PubMed ID: 3615497
    [No Abstract] [Full Text] [Related]

  • 4. Sickle cell pain & hydroxyurea.
    Day SW, Wynn LW.
    Am J Nurs; 2000 Nov; 100(11):34-8; quiz 38-9. PubMed ID: 11103633
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hydroxyurea therapy: improving the lives of patients with sickle cell disease.
    Anderson N.
    Pediatr Nurs; 2006 Nov; 32(6):541-3. PubMed ID: 17256291
    [Abstract] [Full Text] [Related]

  • 7. Pharmacologic manipulation of fetal hemoglobin levels in sickle cell diseases and thalassemia: promise and reality.
    Pearson HA.
    Adv Pediatr; 1996 Nov; 43():309-34. PubMed ID: 8794181
    [No Abstract] [Full Text] [Related]

  • 8. Levels of fetal hemoglobin necessary for treatment of sickle cell disease.
    Noguchi CT, Rodgers GP, Serjeant G, Schechter AN.
    N Engl J Med; 1988 Jan 14; 318(2):96-9. PubMed ID: 2447498
    [No Abstract] [Full Text] [Related]

  • 9. Magnetic resonance imaging, percentage of dense cells and serum prostanoids as tools for objective assessment of pain crisis: a preliminary report.
    Mankad VN, Williams JP, Harpen M, Longenecker G, Brogdon B, Moore B.
    Prog Clin Biol Res; 1987 Jan 14; 240():337-50. PubMed ID: 3615498
    [No Abstract] [Full Text] [Related]

  • 10. Painful crisis and dense echinocytes: effects of hydration and vasodilators.
    Warth JA, Rucknagel DL.
    Prog Clin Biol Res; 1987 Jan 14; 240():429-49. PubMed ID: 3615503
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiologically based drug treatment of sickle cell disease.
    Steinberg MH.
    Trends Pharmacol Sci; 2006 Apr 14; 27(4):204-10. PubMed ID: 16530854
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of hydroxyurea in the management of sickle cell anemia in adults.
    Charache S.
    Semin Hematol; 1997 Jul 14; 34(3 Suppl 3):15-21. PubMed ID: 9317197
    [Abstract] [Full Text] [Related]

  • 13. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Jul 14; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 14. Treatment of sickle cell anemia with hydroxyurea and erythropoietin.
    Goldberg MA, Brugnara C, Dover GJ, Schapira L, Charache S, Bunn HF.
    N Engl J Med; 1990 Aug 09; 323(6):366-72. PubMed ID: 1695325
    [Abstract] [Full Text] [Related]

  • 15. Hydroxyurea increases fetal hemoglobin production in sickle cell anemia.
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B, Nathan DG.
    Trans Assoc Am Physicians; 1984 Aug 09; 97():268-74. PubMed ID: 6085528
    [No Abstract] [Full Text] [Related]

  • 16. Fetal hemoglobin, sickling, and sickle cell disease.
    Charache S.
    Adv Pediatr; 1990 Aug 09; 37():1-31. PubMed ID: 1702260
    [Abstract] [Full Text] [Related]

  • 17. Approach to the vaso-occlusive crisis in adults with sickle cell disease.
    Yale SH, Nagib N, Guthrie T.
    Am Fam Physician; 2000 Mar 01; 61(5):1349-56, 1363-4. PubMed ID: 10735342
    [Abstract] [Full Text] [Related]

  • 18. Sickle cell painful crises: a multifactorial event.
    Nagel RL, Fabry ME, Billett HH, Kaul DK.
    Prog Clin Biol Res; 1987 Mar 01; 240():361-80. PubMed ID: 3615500
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacologic stimulation of Hb F in patients with sickle cell anemia.
    Galanello R, Veith R, Papayannopoulou T, Stamatoyannopoulos G.
    Prog Clin Biol Res; 1985 Mar 01; 191():433-45. PubMed ID: 2413479
    [No Abstract] [Full Text] [Related]

  • 20. Therapies to increase fetal hemoglobin in sickle cell disease.
    Steinberg MH.
    Curr Hematol Rep; 2003 Mar 01; 2(2):95-101. PubMed ID: 12901139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.